Simplifying breast cancer advances
Two technologies, many advantages
Explore relevant breast cancer targets
Reliably test PIK3CA mutations
Interested in actionable PIK3CA mutations in breast cancer? Detect them with confidence.
DNA repair status is relevantLearn how our homologous recombination repair (HRR) panel will expand your biomarker coverage beyond BRCA1/2.
Comprehensive tumor profilingThe QIAseq Pan-cancer Multimodal Panel allows simultaneous profiling of DNA variants and RNA fusions.
1. https://www.who.int/news-room/fact-sheets/detail/breast-cancer. Accessed: Sept 13, 2021.
2. Litton, J.K., Burstein, H.J., Turner, N.C. (2019) Molecular Testing in Breast Cancer. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e1-e7. doi: 10.1200/EDBK_237715.